Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States

Int J Cardiol. 2023 Jan 1:370:143-148. doi: 10.1016/j.ijcard.2022.10.135. Epub 2022 Nov 7.

Abstract

Current estimates suggest that a patent foramen ovale (PFO) may exist in up to 25% of the general population and is a potential risk factor for embolic, ischemic stroke. PFO closure complications include bleeding, need for procedure-related surgical intervention, pulmonary emboli, device malpositioning, new onset atrial arrhythmias, and transient atrioventricular block. Rates of PFO closure complications at a national level in the Unites States remain unknown. To address this, we performed a contemporary nationwide study using the 2016 and 2017 Nationwide Readmissions Database (NRD) to identify patterns of readmissions after percutaneous PFO closure. In conclusion, our study showed that following PFO closure, the most common complications were atrial fibrillation/atrial flutter followed by acute heart failure syndrome, supraventricular tachycardia and acute myocardial infarction.

Keywords: Nationwide readmissions database; Patent foramen ovale.

MeSH terms

  • Atrial Fibrillation* / epidemiology
  • Atrial Flutter*
  • Cardiac Catheterization / adverse effects
  • Foramen Ovale, Patent* / diagnosis
  • Foramen Ovale, Patent* / epidemiology
  • Foramen Ovale, Patent* / surgery
  • Humans
  • Recurrence
  • Risk Factors
  • Septal Occluder Device* / adverse effects
  • Stroke* / complications
  • Stroke* / etiology
  • Treatment Outcome
  • United States / epidemiology